Literature DB >> 31608505

A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.

Kei Fujikawa1, Satoshi Teramukai1, Isao Yokota2, Takashi Daimon3.   

Abstract

Basket trials simultaneously evaluate the effect of one or more drugs on a defined biomarker, genetic alteration, or molecular target in a variety of disease subtypes, often called strata. A conventional approach for analyzing such trials is an independent analysis of each of the strata. This analysis is inefficient as it lacks the power to detect the effect of drugs in each stratum. To address these issues, various designs for basket trials have been proposed, centering on designs using Bayesian hierarchical models. In this article, we propose a novel Bayesian basket trial design that incorporates predictive sample size determination, early termination for inefficacy and efficacy, and the borrowing of information across strata. The borrowing of information is based on the similarity between the posterior distributions of the response probability. In general, Bayesian hierarchical models have many distributional assumptions along with multiple parameters. By contrast, our method has prior distributions for response probability and two parameters for similarity of distributions. The proposed design is easier to implement and less computationally demanding than other Bayesian basket designs. Through a simulation with various scenarios, our proposed design is compared with other designs including one that does not borrow information and one that uses a Bayesian hierarchical model.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  Bayesian predictive sample size determination; Jensen-Shannon divergence; basket trial; clinical trial design; interim analysis

Mesh:

Year:  2019        PMID: 31608505     DOI: 10.1002/bimj.201800404

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  2 in total

Review 1.  The role of basket trials in drug development for neurodegenerative disorders.

Authors:  Jeffrey Cummings; Arturo Montes; Sana Kamboj; Jorge Fonseca Cacho
Journal:  Alzheimers Res Ther       Date:  2022-05-25       Impact factor: 8.823

2.  INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies.

Authors:  Cornelis M van Tilburg; Ruth Witt; Melanie Heiss; Kristian W Pajtler; Christoph Plass; Isabel Poschke; Michael Platten; Inga Harting; Oliver Sedlaczek; Angelika Freitag; David Meyrath; Lenka Taylor; Gnana Prakash Balasubramanian; Natalie Jäger; Elke Pfaff; Barbara C Jones; Till Milde; Stefan M Pfister; David T W Jones; Annette Kopp-Schneider; Olaf Witt
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.